Reata Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for patients with serious or life-threatening diseases.
No data available for RECURSION PHARMACEUTICALS INC CLAS. Target value per method: min. 100%
Greenhouse Gas Emissions
RECURSION PHARMACEUTICALS INC CLAS emits 93% of its CO₂ budget of 4,216 tons of CO₂ equivalent. Target value per method: max. 100% of CO₂ budget
Supply Chain
Taking into account the entire supply chain, RECURSION PHARMACEUTICALS INC CLAS emits 7,6 times its CO₂ budget of 4,216 tons of CO₂ equivalent. Target value per method: max. 100% of CO₂ budget
Recycling and Recovery of Waste
RECURSION PHARMACEUTICALS INC CLAS recycles 44,4% of its waste. Target value per method: min. 75%
Society
65%
Union Formation and Collective Bargaining Power
No data available for RECURSION PHARMACEUTICALS INC CLAS. Target value per method: min. 80%
CEO Pay Ratio
CEO Chris Gibson earns 28 times the median salary of employees. Target value per method: max. 30 times
Employee Turnover Rate
RECURSION PHARMACEUTICALS INC CLAS has an employee turnover rate of 17%. Target value per method: max. 10%
Harassment and Discrimination at the Workplace
RECURSION PHARMACEUTICALS INC CLAS meets 4 quality criteria for handling harassment and discrimination at the workplace. Target value per method: 4 quality criteria
Gender
95%
Women on Board
RECURSION PHARMACEUTICALS INC CLAS has 37,5% women across its top leadership and supervisory bodies. Target value per method: min. 40%
Gender Pay Gap
RECURSION PHARMACEUTICALS INC CLAS has a gender pay gap of 0%. Target value per method: max. 3%
Women in Management
RECURSION PHARMACEUTICALS INC CLAS employs 37% female managers. Target value per method: min. 40%
Glass Ceiling
The proportion of women in senior management at RECURSION PHARMACEUTICALS INC CLAS is 84,1% of the proportion of women in the overall workforce. Target value per method: min. 90%
Sustainable [100]
Almost sustainable [67-99]
Moderate [34-66]
Not sustainable [0-33]
No data
Renewable Energy
No data available for RECURSION PHARMACEUTICALS INC CLAS. Target value per method: min. 100%
Greenhouse Gas Emissions
RECURSION PHARMACEUTICALS INC CLAS emits 93% of its CO₂ budget of 4,216 tons of CO₂ equivalent. Target value per method: max. 100% of CO₂ budget
Supply Chain
Taking into account the entire supply chain, RECURSION PHARMACEUTICALS INC CLAS emits 7,6 times its CO₂ budget of 4,216 tons of CO₂ equivalent. Target value per method: max. 100% of CO₂ budget
Waste Recycling
RECURSION PHARMACEUTICALS INC CLAS recycles 44,4% of its waste. Target value per method: min. 75%
Sustainable [100]
Almost sustainable [67-99]
Moderate [34-66]
Not sustainable [0-33]
No data
We measure the sustainability of companies based on 12 criteria.Indicators range from 0 to 100: values from 0 to 33 are shown in red (“not sustainable”), values from 34 to 66 in yellow (“moderate”), values from 67 to 99 in light green (“almost sustainable”), and a value of 100 in green (“sustainable”). Learn more about our method.
Look at that!
I checked the impact of this company
RECURSION PHARMACEUTICALS INC CLAS
US75629V1044
Sustainable [100]
Almost sustainable [67-99]
Moderate [34-66]
Not sustainable [0-33]
powered by
www.moneycare.io
Compare RECURSION PHARMACEUTICALS INC CLAS with ...
RECURSION PHARMACEUTICALS INC CLAS
?
Impact Score
Climate
Society
Gender
43%
65%
95%
0%
0%
0%
RECURSION PHARMACEUTICALS INC CLAS
?
Impact Score
Climate
Renewable Energy
—
Greenhouse Gas Emissions
100%
Supply Chain
13%
Waste Recycling
59%
Society
Collective Agreements
—
CEO Pay Ratio
100%
Employee Turnover Rate
59%
Anti-Discrimination
100%
Gender
Women on Board
94%
Gender Pay Gap
100%
Women in Management
93%
Glass Ceiling
93%
Sources of sustainability performance
Metric
Value
Unit
Year
PDF Name
PDF Page
No sources found.
Note: The PDF pages given here refer to the page in the PDF document, which is not necessarily the one found in the footer of the page. For example, page 10 is the 10th page in the document, even if it is labeled as page 8.